Survival trends among patients with metastatic non–small cell lung cancer before and after the approval of immunotherapy in the United States: A Surveillance, Epidemiology, and End Results database–based study
Yating Wang,
Kyle Kondrat,
Janak Adhikari
et al.
Abstract:BackgroundIn 2015, the US Food and Drug Administration approved nivolumab as the first immunotherapy for patients with advanced non–small cell lung cancer (NSCLC). However, population‐based survival benefit studies after the introduction of immunotherapy in lung cancer are lacking. This study examined overall survival (OS) and cancer‐specific survival in patients with NSCLC in the pre immunotherapy and immunotherapy eras.MethodsThis study used the Surveillance, Epidemiology, and End Results database, which spa… Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.